74. 下垂体性PRL分泌亢進症 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 21 / 薬物数 : 31 - (DrugBank : 11) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 65
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Barley
Huashan Hospital Affiliated to Fudan University
2022 Phase 0 ChiCTR2200056078 China
Bromocriptin 2.5MG, 2-3 times A DAY
Second Affiliated Hospital, School of Medicine, Zhejiang University
2024 - NCT06556186 -
Bromocriptine
First affiliated hospital of Sun Yat-sen University
2012 - ChiCTR-ONC-12002194 -
Huashan Hospital Affiliated to Fudan University
2022 Phase 0 ChiCTR2200056078 China
Cabergoline
Federico II University
2007 - NCT00460616 Italy
Seoul National University Hospital
2018 - NCT03457389 Korea, Republic of
Universidade Federal do Rio de Janeiro
2010 Phase 2/Phase 3 NCT01620138 Brazil
Clomiphene citrate
Federal University of São Paulo
2004 Phase 2 NCT00697814 Brazil
Curcumin
Mashhad University of Medical Sciences
2011 Phase 1 NCT01344291 Iran, Islamic Republic of
Dexamethasone
National Cancer Institute (NCI)
2010 Phase 1 NCT01088763 Canada;United States
Diagnostic laboratory biomarker analysis
National Cancer Institute (NCI)
2010 Phase 1 NCT01088763 Canada;United States
Dopamine agonist treatment
First Affiliated Hospital, Sun Yat-Sen University
2016 - NCT03353025 China
Dopamine agonists
Leiden University Medical Center
2019 Phase 4 NCT04107480 Netherlands
Endoscopic trans-sphenoidal adenoma resection
Leiden University Medical Center
2019 Phase 4 NCT04107480 Netherlands
Gamma-secretase/notch signalling pathway inhibitor RO4929097
National Cancer Institute (NCI)
2010 Phase 1 NCT01088763 Canada;United States
Genotropin 12MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin 5.3MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.2MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.4MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.6MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.8MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 1.0MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 1.2MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
HCQ/CQ and CAB combined treatment
Zhebao Wu
2018 - NCT03400865 China
Lapatinib
Cedars-Sinai Medical Center
2009 Phase 2 NCT00939523 United States
Pasireotide
Memorial Sloan Kettering Cancer Center
2024 Phase 2 NCT06295952 United States
NOVARTIS FARMA
2009 - EUCTR2008-007348-32-IT France;Germany;Italy;Spain
Novartis Pharma Services AG
2009 Phase 2 EUCTR2008-007348-32-FR France;Germany;Italy;Spain
2009 Phase 2 EUCTR2008-007348-32-DE Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Italy;Mexico;Russian Federation;South Africa;Spain;United States
Universidade Federal do Rio de Janeiro
2010 Phase 2/Phase 3 NCT01620138 Brazil
Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie
2008 - EUCTR2006-007036-95-DE Germany
Pharmacological study
National Cancer Institute (NCI)
2010 Phase 1 NCT01088763 Canada;United States
Ropinirole
Columbia University
2016 Phase 1/Phase 2 NCT03038308 United States
SF-36 and hads
Memorial Sloan Kettering Cancer Center
2024 Phase 2 NCT06295952 United States
SOM230
NOVARTIS FARMA
2009 - EUCTR2008-007348-32-IT France;Germany;Italy;Spain
Novartis Pharma Services AG
2009 Phase 2 EUCTR2008-007348-32-FR France;Germany;Italy;Spain
2009 Phase 2 EUCTR2008-007348-32-DE Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Italy;Mexico;Russian Federation;South Africa;Spain;United States
Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie
2008 - EUCTR2006-007036-95-DE Germany
Somatropin
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Surgery
Zhebao Wu
2018 - NCT03717454 -
Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy
Second Affiliated Hospital, School of Medicine, Zhejiang University
2024 - NCT06556186 -
Transsphenoidal surgery treatment
First Affiliated Hospital, Sun Yat-Sen University
2016 - NCT03353025 China
Huashan Hospital Affiliated to Fudan University
2022 Phase 0 ChiCTR2200056078 China
Bromocriptin 2.5MG, 2-3 times A DAY
Second Affiliated Hospital, School of Medicine, Zhejiang University
2024 - NCT06556186 -
Bromocriptine
First affiliated hospital of Sun Yat-sen University
2012 - ChiCTR-ONC-12002194 -
Huashan Hospital Affiliated to Fudan University
2022 Phase 0 ChiCTR2200056078 China
Cabergoline
Federico II University
2007 - NCT00460616 Italy
Seoul National University Hospital
2018 - NCT03457389 Korea, Republic of
Universidade Federal do Rio de Janeiro
2010 Phase 2/Phase 3 NCT01620138 Brazil
Clomiphene citrate
Federal University of São Paulo
2004 Phase 2 NCT00697814 Brazil
Curcumin
Mashhad University of Medical Sciences
2011 Phase 1 NCT01344291 Iran, Islamic Republic of
Dexamethasone
National Cancer Institute (NCI)
2010 Phase 1 NCT01088763 Canada;United States
Diagnostic laboratory biomarker analysis
National Cancer Institute (NCI)
2010 Phase 1 NCT01088763 Canada;United States
Dopamine agonist treatment
First Affiliated Hospital, Sun Yat-Sen University
2016 - NCT03353025 China
Dopamine agonists
Leiden University Medical Center
2019 Phase 4 NCT04107480 Netherlands
Endoscopic trans-sphenoidal adenoma resection
Leiden University Medical Center
2019 Phase 4 NCT04107480 Netherlands
Gamma-secretase/notch signalling pathway inhibitor RO4929097
National Cancer Institute (NCI)
2010 Phase 1 NCT01088763 Canada;United States
Genotropin 12MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin 5.3MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.2MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.4MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.6MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.8MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 1.0MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 1.2MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
HCQ/CQ and CAB combined treatment
Zhebao Wu
2018 - NCT03400865 China
Lapatinib
Cedars-Sinai Medical Center
2009 Phase 2 NCT00939523 United States
Pasireotide
Memorial Sloan Kettering Cancer Center
2024 Phase 2 NCT06295952 United States
NOVARTIS FARMA
2009 - EUCTR2008-007348-32-IT France;Germany;Italy;Spain
Novartis Pharma Services AG
2009 Phase 2 EUCTR2008-007348-32-FR France;Germany;Italy;Spain
2009 Phase 2 EUCTR2008-007348-32-DE Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Italy;Mexico;Russian Federation;South Africa;Spain;United States
Universidade Federal do Rio de Janeiro
2010 Phase 2/Phase 3 NCT01620138 Brazil
Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie
2008 - EUCTR2006-007036-95-DE Germany
Pharmacological study
National Cancer Institute (NCI)
2010 Phase 1 NCT01088763 Canada;United States
Ropinirole
Columbia University
2016 Phase 1/Phase 2 NCT03038308 United States
SF-36 and hads
Memorial Sloan Kettering Cancer Center
2024 Phase 2 NCT06295952 United States
SOM230
NOVARTIS FARMA
2009 - EUCTR2008-007348-32-IT France;Germany;Italy;Spain
Novartis Pharma Services AG
2009 Phase 2 EUCTR2008-007348-32-FR France;Germany;Italy;Spain
2009 Phase 2 EUCTR2008-007348-32-DE Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Italy;Mexico;Russian Federation;South Africa;Spain;United States
Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie
2008 - EUCTR2006-007036-95-DE Germany
Somatropin
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Surgery
Zhebao Wu
2018 - NCT03717454 -
Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy
Second Affiliated Hospital, School of Medicine, Zhejiang University
2024 - NCT06556186 -
Transsphenoidal surgery treatment
First Affiliated Hospital, Sun Yat-Sen University
2016 - NCT03353025 China